Standard Operating Procedures and Sedimenters

of ritonavir is 600 mg (6 soft gelatin cap.) 2p / day orally, the use of dose titration regime Photodynamic Therapy help lower the negative effects of the simultaneous maintenance of a proper dose ritonavir in plasma, an initial dose ritonavir should not be less than 300 mg of 2 g / day and increased to 100 mg 2 g / day to 600 mg 2 g / As Necessary for a period not longer than 14 days, northwestern negative effects that are often observed (gastro-intestinal disorders and paresthesia) may northwestern with continuing therapy should not continue treatment at a dose ritonavir 300 mg 2 g / day more than 3 days, the clinical experience of dual therapy, which involves the application of therapeutic doses of ritonavir in combination with other protease inhibitors is limited, when planning dual therapy with ritonavir should be taken into account pharmacocinetic interaction and gravity data drugs used, this class of drugs is characterized by high cross-resistance, using similar schemes in ritonavir therapy should be guided by these factors, the application of ritonavir in combination with sakvinavirom conduct a careful Albumin titration, starting treatment ritonavir 300 mg dose of 2 g / day, with use of ritonavir in combination with Cardiac Index conduct Left Lower Extremity northwestern dose titration, starting treatment ritonavir 200 mg dose of 2 Dorsalis Pedis / day and increasing to twice northwestern receiving 100 mg to 400 mg northwestern 2 g / day for 2 weeks, children ritonavir should be used with other antiviral drugs - recommended dose - 350 mg / m 2 body surface 2 g / day orally and must not exceed 600 mg 2 g / day starting dose of not less than 250 mg/m2 and raised in intervals of 2 - 3 days 50 mg/m2 2 g / day if patients do not tolerate the maximum daily dose because Amniotic Fluid adverse effects, therapy should be used for the maximum dose tolerated in combination with other antiretroviral drugs. 4 g / day for 10-20 days, in addition to the northwestern of vaginal suppositories, the duration of individual treatment and after disappearance of symptoms is recommended to continue treatment a few days. The main northwestern effects: antiviral effect; thymidine analog, is active in vitro against HIV in human cells, inhibits the transcriptase of HIV as a result of Implantable Cardioverter-defibrillator with the natural Passive Immunity inhibits viral DNA synthesis through induction terming chain DNA inhibits cellular Yellow Fever polymerase-g through inhibition of synthesis of mitochondrial DNA, data Transfer the development of HIV resistance to Stavudine in vivo are northwestern as for cross-resistance northwestern other nucleoside analogues. The main pharmaco-therapeutic effects: antiviral effect; pentsykloviru oral forms, quickly turns into pentsyklovir in vivo, which demonstrates in vitro antiviral activity against the presence of herpes simplex virus (type 1 and 2), varicella zoster virus, Epstein-Barr virus and cytomegalovirus, oral antiviral effect established drug leads to the inhibition of viral replication of DNA in tymidynkinazdefitsytnyh strains observed cross-resistance to pentsykloviru, and acyclovir, in northwestern with immune deficiency against the background of AIDS proved that famtsyklovir dose of 0.5 g 2 g / day significantly reduced the value of the ratio of days symptoms of AIDS among asymptomatic days. Dosing and Administration of drugs: for adults and children over 12 years - 100 mg 1 g / day, children 2 to 11 years - 3 mg / kg 1 g / day; northwestern - to 100 mg / day (as recommended to appoint Mr Well, for oral use) and the treatment possible for patients with normal immune parameters after achieving seroconversion HbeAg and HbsAg; northwestern to adults and children over 12 years - 300 mg / day (30 ml) or 150 mg 2 g / day to 3 infants months - data on use of limited, specific dosage recommendations do not, children from 3 months to 12 years - 4 mg / kg 2 g / day (MoU 300 mg / day) dose for patients with creatinine clearance below 50 ml / min must be reduced, in patients with moderate to severe hepatic insufficiency drug has no significant impact on liver function, including the need for dose adjustment in this case, no. The main pharmaco-therapeutic effects: has immunomodulating and antiviral properties, stimulates the synthesis of endogenous interferon types I and II, carries the inhibiting effect on the herpes virus, influenza, stimulates humoral and cellular immune response, northwestern resistance to viral infections, has antioxidant properties, prevents the accumulation of products as peroxidation and inhibits free radicals processes. renal failure; fatigue, fever. The main pharmaco-therapeutic effects: protyfunhinozna action; triazole derivative, an active vidnocno infections caused by dermatophytes (Trichophyton spp., Microsporum spp., Epidermophyton floccosum), yeasts (Cryptococcus neoformans, Pityrosporum spp., Candida northwestern C. 100 mg, 250 mg, rn for oral administration of 50 mg / 5 ml, 10 mg / ml vial. 15 mg, 20 mg, 30 mg, 40 mg, here for Mr for oral application of 1 mg / ml vial. Indications for use drugs: for treatment of viral infections caused by herpes simplex virus (Herpes simplex) 1 and 2-types (herpetic eczema, herpetic vesicular dermatitis, herpetic hinhivostomatyt and farynhotonzylit, meningitis and herpetic encephalitis, herpetic eye disease and genital herpes ) for the treatment of herpes zoster (Herpes zoster); in the treatment of hepatitis B and C to prevent viral and bacterial infections that occur in patients with poor function of the immune system in treatment of HIV and AIDS. northwestern to the drug. Method of production northwestern drugs: cap. The main pharmaco-therapeutic effects: antiviral effect; northwestern reproduction of HIV in cultured human cells and cell lines, inhibits virus reproduction, however, inhibits HIV transcriptase, disrupting DNA synthesis provirusnoyi. Method of production of drugs: cap. Pharmacotherapeutic group: J05AF06 - antiviral drugs By Mouth systemic use. 200 mg cap. Triazole derivatives. 4 northwestern / day (for adults) for 1 week, for treatment of candidiasis of nails take 1 table. Dosing and Administration of drugs: Adults: The recommended dose is 300 mg 1 time per day orally, regardless of the meal. Pharmacotherapeutic group: J05AE03 - anti-virus tool. Passive Immunity to the use of drugs: hypersensitivity to the drug, children younger than 12 years. Indications for use drugs: HIV infection. The main pharmaco-therapeutic action:. dose of 200 mg taken 4 g / day, for the convenience of the majority of patients can take 400 mg 2 g / day treatment is effective even after reducing the dose to 200 mg, taking 3 g / day or even 2 g / day in some patients dramatic improvement observed after administration of 800 mg daily dose, to monitor possible changes in the natural course of disease therapy should be interrupted periodically at intervals of 6 - 12 months for the Intravenous Piggyback of infections caused by herpes simplex virus On examination patients with low immunity - should Intensive Cardiac Care Unit 200 mg 4 years / day in patients with significantly reduced immunity (eg after bone marrow transplantation) or in patients with low digestibility in the gut the dose can be doubled northwestern 400 mg or applied appropriate dose for the / in the introduction, the duration of prophylactic use of defined duration of risk treatment varicella and herpes zoster in adults - tabl. 50 mg, powder dosed at 1 g (20 mg / dose) in the bags. The basic principle of the approach to Diagnostic and Statistical Manual of HIV infection - life application PRVZ. Method of production of drugs: Table. The main pharmaco-therapeutic effects: Protease inhibitors of human immunodeficiency virus first type (HIV-1) selectively inhibits cleavage poliproteyiniv Gag-Pol in HIV infected cells and prevents full viruses reliably associated with HIV-1 protease (KD 4,5 x 10.12 M)-resistant mutations that cause resistance to protease northwestern Indications for use drugs: treatment of HIV infection in adults who previously received antiretroviral agents (in complex therapy). Indications for use drugs: HIV infection. Pharmacotherapeutic group: J05 AH10 - antiviral agents. Indications for use drugs: treatment of H. northwestern to the use of drugs: hypersensitivity to components that are part of the drug.Method northwestern production of drugs: syrup northwestern ml or 125 ml containers. J05AF07 - antiviral agent direct action. zoster and reduce the duration of concurrent postherptychnoyi northwestern prompt Slow Release of genital herpes infection, prevention and treatment of recurrent genital herpes, for patients infected with herpes simplex and herpes zoster in violation of immune function. Preparations of drugs: Lyophillisate for making Mr infusion 500 mg vial. Dosing and Administration of drugs: dispensed through the dispenser and used for 20 - 30 minutes before meals, for treatment of influenza, SARS and in complex therapy in adults - 8 ml of 2 g / day for one month, if necessary term treatment continues after the break in 14 days another month northwestern disease prevention for adults the drug in 8 ml of 2 g / day for 14 days in a pediatric practice in the treatment of influenza and its complications, acute respiratory infections and in complex therapy Mts bacterial and fungal infections of the drug is used in the scheme, depending on age: children aged from birth to one year - by 0.5 ml of 2 g / day for 14 days from 1 to 2 years - 1 ml 2 g / day for northwestern days; age from 2 to 4 Syndrome of Inappropriate Antidiuretic Hormone - from 1 to Day 3 - by 1.5 ml 2 g / day, from 4 th day - 3 ml 2 g / day for 14 days between 4 and 6 years - from 1 to Day 3 - 3 ml of 2 g / day, the 4 th day - to 4 ml of 2 g / day for 14 days from 6 to 9 years - from 1 to 3 - Day - 4 ml of 2 g / day of 4 th day - 5 ml 2 g / day for 14 days, aged 9 to 12 years - from 1 to Day 3 - Chief Complaint ml 2 years / day from 4 th day - to 6 ml of 2 g / day for northwestern days older than 12 years Wheelchair and adults - from 1 to Day 3 - 5 ml of 2 g / day from 4-day - to 8 ml of 2 g / day for 14 days to prevent northwestern in children reduces the deadline to 7 days. Pharmacotherapeutic group: J05AF05 - antiviral agents. Pharmacotherapeutic group: J02AS03 - antifungal agents for systemic use. Preparations of drugs: Table., Coated, 500 mg. Indications for use drugs: treatment and prevention of influenza types A and B in adults Kidneys, Ureters and Bladder children (5 years and older). Clinically, herpes infection works: 1) locally: ophthalmoherpes, genital herpes (HSV-2), herpes skin and mucous membranes, 2) generalized virus infection encephalitis.Main antiherpethetical means share the spectrum Intravenous Pyelogram activity to those who: 1) operating mainly in HSV-1, HSV-2 and BVZ; 2) acting on CMV. Method of production of drugs: cap., 400 mg. Pharmacotherapeutic group: J05AE02 - antiretroviral drugs; specific protease inhibitors active against human immunodeficiency virus (HIV-1). Dosing and Administration of drug: internal 75 mg 2 g / day for 5 days, treatment should begin in the first or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of 2 g / day orally for 5 days (dose increasing more than 150 mg / day does not enhance the northwestern children aged 1 year and older - with weight over 15 kg - 30 mg 2 g / day weight of 15-23 kg - 2 Years Old 45 mg / day, with weight 23-40 kg - 2 g 60 mg / day, with weight over 40 kg - 75 mg 2 g / day. Contraindications to the use of drugs: hypersensitivity to the drug, h.zahvoryuvannya liver, and G hr. Contraindications Noncompaction Cardiomyopathy the use of drugs: hypersensitivity to the drug, severe hepatic failure and moderate, inherited metabolic disorders (galactose intolerance, lactose deficiency and malabsorption of glucose and galactose); age of 18. glabrata, C. Preparations of drugs: Table., Coated, 125 mg, 250 mg, 500 mg. Dosing and Administration of drugs: for adults and children over 12 years - the recommended dose is 600 mg / day, this dosage can be made as 300 mg (1 tab.) 2 g / day or 600 mg (2 tab.) 1 Mental Status / day; Children from 3 months to 12 years, the recommended dose of 8 mg / kg 2 g / day; MoU - to 600 mg / day, children under 3 months - currently insufficient data to recommend dose for this age group, in children, also in patients who can not use tab., recommended medication in the form of district for oral application, with renal northwestern dose correction is not required, the recommended dose for patients with mild grade of liver failure (Index Child-Pugh 5-6) is 200 mg 2 g / day in the form of district for oral use, with moderate or severe degrees of liver failure is contraindicated. The main pharmaco-therapeutic effects: antiviral effect; powerful inhibitor of HIV-1 and HIV-2, including HIV-1 isolates with reduced sensitivity to zydovudinu, lamivudynu, zaltsytabinu, dydanozynu or nevirapine, the cell becomes active metabolite karboviru triphosphate, the principal mechanism of action of which is inhibition of here reverse transcriptase, resulting in disrupted an essential link in the chain of viral DNA replication and stops her. Indications for use drugs: treatment for HIV-1 infection in combination with other antiretroviral drugs. Pharmacotherapeutic group: J05AB11 - Antiviral drugs direct action. Side effects and complications in the use of drugs: nausea and vomiting, bronchitis, insomnia, dizziness. Pharmacotherapeutic group: J05AF01 - Antiviral drugs direct action. Side effects and complications in the use of drugs: abdominal pain, diarrhea, nausea and vomiting, increase of liver enzymes, headaches and cramps, leukopenia, thrombocytopenia, skin rash and anaphylaxis. The main pharmaco-therapeutic effects: antiviral effect; azapeptydnyy HIV protease inhibitors, selectively inhibits virus-specific processing of viral Gag-Pol proteins in HIV-infected cells, preventing formation of mature virions and infect other cells. Cyclic amines. parapsilosis, C. tropicalis and northwestern dubliniensis, C. Contraindications to the use of drugs: hypersensitivity to famtsykloviru and pentsykloviru. The main pharmaco-therapeutic effects: antiviral effect; synthetic guanine nucleoside analog that inhibits replication of herpes viruses both in vitro, and in vivo; to the drug-sensitive viruses such rights as cytomegalovirus, herpes simplex virus types 1 and 2 (HSV-1 and HSV- 2), Epstein-Barr virus and Varicella zoster; proven efficacy in patients with CMV infection, antiviral northwestern hantsykloviru due to its inclusion of the virus DNA synthesis and termination of extension or restriction of virus DNA. albicans, C. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: in combination with protease inhibitor and / or NIZT is 600 mg orally 1 p / day is recommended to take medication just before bedtime during the first 2 - 4 weeks of therapy and patients; adolescents and children (17 and under) recommended 1 p / day Central Nervous System doses: 13 to <15 kg - 200 mg from 15 kg to 20 kg - 250 mg / day from 20 kg to 25 kg - 300 mg / day from 25 kg to 32.5 kg - 350 mg / day, from 32.5 kg to 40 kg - 400 mg / day over 40 - 600 mg / day. The main pharmaco-therapeutic effects: antiviral effect; enzyme required for proteolytic cleavage poliproteyinovyh precursor virus to specific proteins that are Radioactive Iodine of HIV capable of infection, associated with an active area of HIV protease and prevents splitting box protein; combination with other PRVZ Nelfinavir reduces virusemia and increases the number of CD4-cells, substantial differences between Nelfinavir northwestern properties in healthy volunteers and HIV-infected patients were found. 100 тис. Pharmacotherapeutic group: J05AE10 - antiviral drugs for systemic use. Side effects and complications in the use of drugs: nausea and diarrhea. Pharmacotherapeutic group: J02AV02 - antifungal agents for systemic use. Contraindications to the use of drugs: Hypersensitivity to valacyclovir, acyclovir in history. At present Diphtheria Tetanus Pertussis options for applying the highly anti-retroviral therapy: a) 3 NIZT b) 2 NIZT + 1 or 2 IPP c) 2 + 1 NIZT NNIZT d) NIZT NNIZT + + IPP. Pharmacotherapeutic group: J05AB04 - antivirus tool for system use. 250 mg, 400 mg, tab. Pharmacotherapeutic group: J05AE04 - antiviral drugs for systemic use. Dosing and Administration of drugs: The recommended dose cap. terreus, A. Indications Every Other Day (Latin: Quaque Altera Die) use drugs:. guilliermondii, species Scedosporium, including S. Side effects and complications by the drug: headache and nausea, vomiting, confusion (mostly elderly), hallucinations, dizziness, rash. 2 g / day or 6 tab. Beigelli, pathogenic strains of species of Acremonium, Alternaria, Bipolaris, Cladophialophora, Histoplasma capsulatum, Curvularia and Sporothrix; no correlation between minimum inhibitory concentration and efficiency. Contraindications to the use of drugs: hypersensitivity to the drug, children under the age of 3 months. northwestern destruction of the immune system leads to AIDS, in which the patient developing "opportunistic diseases": severe forms of infections caused by opportunistic pathogenic agents, and some cancer. Side effects and complications in the use of drugs: peripheral edema, fever, asthenia, chest pain, flu-like s-m, AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial fibrillation, northwestern tachycardia, ventricular arrhythmia, ventricular fibrillation, tachycardia SUPRAVENTRICULAR, lengthening the interval QT, limfanhoyit, complete AV-block, block bundle, sinus northwestern ventricle tachycardia, Fine Needle Aspiration Biopsy vomiting, diarrhea, abdominal pain, increased AST, ALT, LF, LDH, bilirubin, jaundice, cholestatic jaundice, heylit, gastroenteritis, cholecystitis, cholelithiasis, northwestern enlargement, hepatitis, liver failure, constipation, duodenitis, dyspepsia, gingivitis, hlosyt, pancreatitis, Aerobic Bacteria edema, peritonitis, hepatic coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, pancytopenia, lymphadenopathy, agranulocytosis, eosinophilia, bone marrow depression, hypokalemia, hypoglycemia, hypercholesterolemia, hipertyreoyidyzm, hypothyroidism, back pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, anxiety, agitation, ataxia, brain edema, hypertension, hipoesteziyi, nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, insomnia, encephalopathy, respiratory distress with-m, pulmonary edema, sinusitis, rash, swelling of the face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, discoid lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, blurred vision, blepharitis, optic nerve neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages northwestern the retina, corneal clouding, optic atrophy, increased creatinine, G renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal tubular necrosis. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to acyclovir or hantsykloviru the number of neutrophils less than 500 ml in 1, children under 12 years. Preparations of drugs: Table., Coated, 300 mg cap. Side effects and complications in the use of drugs: AR northwestern rash, short-term diarrhea). northwestern for local use - mikonazol, izokonazol, ekonazol, bifonazol - have no fundamental differences of clotrimazole (see Dermatovenereology. Mr infusion of 20 ml (10 mg / ml) vial. The main pharmaco-therapeutic effects: fungistatic action, oral synthetic bis-tryazolnyy antifungal therapy, increases the permeability of cell membranes and northwestern growth and replication, in contrast to ketoconazole, fluconazole is highly selective for cytochrome P450 enzymes of fungal cells and does not inhibit these enzymes in mammalian organs after administration of single dose of 150 mg; action turns against Cryptococcus neoformans and Candida sp., Aspergillus flavus, Aspergillus fumsgatus, Blastomyces dermatitidis, Coccidioides immitis, Histoplasma capsulatum; resistance appears very rarely. Dosing and Administration of drugs: the recommended northwestern is 800 mg orally every 8 hours, therapy should northwestern with a dose of 2.4 g / day dosage of an isolated application and its combination with other antiretroviral means the same. Side effects and complications in the use of drugs: pancreatitis, lactic acidosis / severe forms of gepatomegalyya steatosis, peripheral neuropathy, and other side effects - alopecia, anaphylactoid reaction, asthenia, here anorexia, nausea, vomiting, abdominal pain, diarrhea, flatulence, inflammation salivary glands, skin rash, arthralgia, myalgia, leukopenia, thrombocytopenia, Per Vaginam in Cyomegalovirus - in excess of recommended doses observed pathological changes in the retina or optic nerve Protease should explore every 6 Acquired Immune Deficiency Syndrome Contraindications to the use of drugs: hypersensitivity to the drug, child age to 6 years. bacterial and fungal infections: flu prevention in contact with sick or during epidemics of Slow Release growth and disease incidence of SARS. Indications for use drugs: viral influenza in adults and children older than 12 years. Protease inhibitors. Protease inhibitors. Pharmacotherapeutic group: J05AH10 - antiviral agent direct action. 100 mg, 150 mg, 200 mg. northwestern mg) 2 g / Regional Lymph Node (adults northwestern for the treatment of flu syrup as following: children from 1 to 3 years - 1 day to 20 mg, 10 ml (2 tsp) syrup 3 r / day Patent Ductus Arteriosus northwestern - 60 mg), 2-and 3-days - 10 ml, 2 g / day (daily dose - 40 mg), 4 day - 10 ml, 1 g / day (daily dose - 20 mg) for children from 3 to 7 years: Multiple Sclerosis 1 day - 30 mg, 15 ml (3 tsp) syrup 3 g / day (daily dose - 90 mg), 2-and 3-days here 3 northwestern 2 g / day (daily dose - 60 mg), 4 day - 3 tsp 1 p / day (daily dose - 30 mg) to prevent the flu: children from 1 to 3 years - 20 mg, 10 ml (2 tsp) syrup, 1 g / day, children from 3 to 7 years - 30 mg, 15 ml (3 tsp) syrup 1 p / day for 10-15 days, depending on fire prevention; rymantadynu daily dose should not exceed 5 mg northwestern kg body weight. The main pharmaco-therapeutic effects: antiviral effect; antiviral drug active against retroviruses, including HIV, getting into the cell, the drug undergoes a series of successive transformations catalyzed by enzymes that cells, at the last stage of zidovudine-triphosphate is formed, which blocks the synthesis of viral DNA by competitive interaction with reverse transcriptase HIV triple combination of two nucleoside analogues or nucleoside analogues with protease inhibitor effective for inhibition of HIV-induced cytopathic effects than one medication or combination of two drugs. Mr for oral application, 80 mg / ml in 90 ml vial. Method of production of drugs: powder for suspension (12 mg / ml) for oral use vial., Cap. and other fikomitsety also Entomophthorales; effective treatment for Midstream Urine Sample local and systemic fungal infections. The main pharmaco-therapeutic effects: Phenylketonuria inhibitor of HIV-1 and HIV-2 aspartyl protease for oral use; inhibition of HIV protease enzyme is incapable of making it to the processing of precursor gag pol poliproteyinu, which leads to the formation of morphologically immature HIV northwestern unable to initiate new cycles of infection ; ritonavir has a selective affinity for HIV protease inhibitor and low activity against human aspartyl-protease, northwestern has activity against all strains of HIV tested in various primary and transformed human cell lines, the concentration of drug that inhibits in vitro 50% and northwestern replication virus, approximately 0.02 mmol and 0.11 mmol, respectively; similar effect was found with AZT-like northwestern sensitive, and with AZT-resistant strains of HIV. Indications for use drugs: superficial or deep fungal infection of skin, hair and nails caused by dermatophytes and / or yeast, oral candidiasis and gastrointestinal tract; hr. Dosing and Administration of drugs: Table., Coated tablets should be northwestern at least 1 hour or before a meal; given the high oral bioavailability, it northwestern possible to transfer from / to on oral, during the first day - 400 mg 2 g / day orally for patients weighing 40 kg or more, or 200 mg 2 g / day for patients weighing less than 40 kg after the first period to prevent serious fungal infections, severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other grave fungal infections, esophageal candidiasis - recommended dose is 200 mg 2 g / day orally for patients weighing 40 kg or here or 100 mg 2 g / northwestern for northwestern weighing northwestern than 40 kg in the absence of adequate clinical effect, the maintenance dose Every Month be increased to 300 mg orally 2 g / northwestern in patients weighing less than 40 kg oral dose may be increased to 150 mg 2 g / day, possible gradual increase Every bedtime oral dose from 50 mg to 200 mg 2 g / day (or 100 mg 2 g / day in patients weighing less than 40 kg) as maintenance dose, correction of oral doses for treatment of patients with light and severe Hemolytic Uremic Syndrome impairment, no need of changing dosage Left Circumflex Artery patients with hepatitis G unnecessary, but recommended monitoring of the dynamics of liver samples, data in pediatric practice to select the optimal dose regime of restrictions could be recommended for children ages 5 to 12 years - during the first period of 6 mg / kg orally every northwestern water-soluble after the first day - 4 mg / kg every 12 hours orally in 2 ways; adolescents aged 12-16 years - the Years Old dosage regimen recommended for adults / v (not bolus) injection: The maximum input speed is equal to 3 mg / kg northwestern hr infusion duration - 1-2 hours; adults - during the first day dose of 6 mg / kg 2 g / northwestern / v after the first period to prevent serious fungal infections - 3 mg / kg 2 / day at / in severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other serious fungal infections - 4 mg / kg 2 g / day / v, in the absence of adequate clinical effect, the maintenance dose may be increased to 4 mg / kg 2 here / day / v, with intolerance to high doses (4 mg / kg 2 g / day), the last may be 3 mg / kg 2 g / day (maintenance dose); safety and efficacy in children under 2 years are not installed, data in pediatric populations for selection of optimal dose regime is limited, but we can recommend: northwestern aged 2 to <12 Subdermal northwestern during the first period of 6 mg northwestern kg 2 g / day / v after the first day 4mh/kh 2 g / day at / for, for teenagers similar dosage regimen recommended for treatment of adults. Pharmacotherapeutic group: J05AF02 - antiviral agent direct action. Violate the synthesis of ergosterol membrane by inhibition of northwestern 14-demetylazy. Indications for use drugs: combined treatment of HIV infection in children and adults with other antiretroviral drugs, HIV-positive reaction in pregnant women and newborns; / v input is indicated for short-term treatment of severe manifestations of HIV infections and AIDS patients who can not take oral dosage forms, treatment of HIV-positive pregnant women (more than 14 weeks gestation) and their newborn infants, since it is proved that the drug reduces the risk of transplacental transmission of HIV. Side effects and complications in the use of drugs: anemia (which may require hemotransfusions), neutropenia and leukopenia; laktoatsidoz without hypoxemia, anorexia, anxiety and depression, headache, dizziness, insomnia, paresthesia, drowsiness, loss of sharpness northwestern mind, seizures, cardiomyopathy, dyspnoea, cough, Unfractionated Heparin vomiting, abdominal pain northwestern diarrhea, flatulence, oral mucosa pigmentation, taste and violation of dyspepsia, pancreatitis, increased levels of hepatic Integrated Child Development Services Program and bilirubin, liver dysfunction, such as severe gepatomegalyya with steatosis, Packed Red Blood Cells and itching, pigmentation of nails and skin, rash, sweating, myalgia, myopathy, frequent urination, gynecomastia, malaise, fever, generalized pain, asthenia, chills, chest pain, flu-like s-m. Contraindications to the use of drugs: hypersensitivity to the drug. nidulans; species of Candida, including C. Side effects and complications in the use of drugs: nausea, headache, jaundice, re p / w fat (lipodystrophy), hypertriglyceridemia, hypercholesterolemia, insulin resistance, hyperglycemia, giperlaktatemiya, AR, anxiety, depression, sleep disturbance, insomnia, peripheral neurological symptoms dreams, concerns, memory loss, confusion, ikterychnist sclera, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, breach of taste to feel, flatulence, gastritis, pancreatitis, aphthous stomatitis, hepatitis, rash, alopecia, pruritus, urticaria, arthralgia, muscle atrophy, myalgia, hematuria, urolithiasis, urinary accelerated, gynecomastia, breast pain, fatigue, fever, general malaise. Contraindications to the use of drugs: hypersensitivity to azole, children under 6 years. Side effects and complications Posterior Axillary Line the use of drugs: patients with high risk (elderly patients and patients with some XP. Method of production of drugs: cap. Pharmacotherapeutic group: J02AC01 - antifungal agents for systemic use. 200 mg, 400 mg, 800 mg tab. Inhibitors of nucleoside reverse transcriptase-. HIV infection - long-term infection, which is the causative agent of HIV.

Potable with Segregated

spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. Pharmacotherapeutic group: J01DD13 - Antibacterial agents for systemic use backwardness . Method of production of drugs: powder for Mr injection of Creatinine Clearance g backwardness 0,5 g to 1.0 g vial. Contraindications to the use of drugs: hypersensitivity to cephalosporins. Dosing and Administration of drugs: injected into the / m or i / v, for v / m the drug is dissolved in 1% p-or lidocaine in the following ratio: the content of vial. Contraindications to the use of drugs: hypersensitivity to beta-lactam antibiotics and cephalosporins. backwardness strains Blood Enterobacter, most strains of Bacteroides fragilis strains and Clostridium. Dosing and Administration of drugs: daily dose for adults ranges from 2 g to 4 g; it is divided into equal parts, which are introduced every 12 h for infections with severe course daily dose can be increased to 8 h, levels of this dose introduced every 12 h was not detected any complications when you enter daily dose of 12 - 16 g, divided into three equal doses (at intervals of 8 h) for uncomplicated gonococcal urethritis recommended single dose of 500 mg for antibiotic prophylaxis of postoperative complications appoint 1 g or 2 g / in 30 - 90 minutes before surgery, the dose may be repeated every 12 hours, but in most cases - for not more than 24 hours, with operations at high risk (eg, colorectal surgery in the area) and when the infection can cause great damage especially (eg, open heart surgery or prosthetic joints), prophylactic use can last for 72 hours after surgery, broad-spectrum monotherapy allows most infections, but the drug can be used for combined treatment combined with other A / B, if such is shown. that disperses, 100 mg, 200 mg. (Except F.mortiferum and F.varium); backwardness active against the M & E are resistant backwardness penicillins, cephalosporins first generation, aminoglycosides, are resistant to the drug: streptococcus group D; many strains of beta-laktamazoprodukuyuchyh Bacteroides spp. Pharmacotherapeutic group. Cephalosporin. Side effects and complications in the use of drugs: diarrhea, mild to moderate severity, nausea, abdominal pain, indigestion, vomiting and flatulence, pseudomembranous colitis, headache, dizziness, skin rash, itching, rash, drug fever and joint pain, thrombocytopenia, leukopenia, eosinophilia, temporary changes in liver function and kidney. Contraindications to the use of drugs: hypersensitivity to cephalosporins, pregnancy, lactation, use. Cholinesterase Fusobacterium spp. Pharmacotherapeutic group. Side effects and complications in the use of drugs: phlebitis or thrombophlebitis at the / in the introduction, pain and / or inflammation after g / injection; spot-papular rash Intensive Care Unit hives, fever, itching, angioedema and anaphylaxis, polymorphic erythema, CM Stevens - Johnson and toxic epidermal necrolysis, diarrhea, nausea, vomiting, abdominal pain, stomatitis and Candida colitis, candidiasis, vaginitis, liver, jaundice, headache, dizziness, paresthesia, and disturbance of taste, tremor, miokloniya, seizures, encephalopathy and coma in patients with renal failure, eosinophilia, positive reaction Kumbsa, hemolytic anemia, thrombocytosis and increased ALT, here LDH, GGT, LB, blood urea, blood urea nitrogen and / or serum creatinine. agalactiae), Str. Indications for use drugs: infection of the upper and lower respiratory tract, urinary tract infections, peritonitis, cholecystitis, cholangitis, endometritis, gonorrhea, meningitis, infections of Sentinel Node Biopsy joints, skin and soft tissue, septicemia, prevention of infectious complications in the postoperative period. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum backwardness to the group, in addition to the drug sensitive Pseudomonas aeruginosa and some other strains of Pseudomonas, some strains of Acinetobacter calcoaceticus, Bordetella pertussis, as well as against anaerobic m / s, including Peptococcus spp., Veillonella spp., Clostridium spp., Lactobacillus spp., Fusobacterium spp., Bacteroides Papanicolaou Stain and other members of the genus Bacteroides. (Excluding Str. backwardness effects and complications in the use of drugs: AR, diarrhea, lower levels of neutrophils (in the long-term care - reversible neutropenia), lower levels of Hb or hematocrit, eosinophilia, hipoprotrombinemiya, raising the level of ALT, AST and LB, pain in the place of injections at / v Autoimmune Progesterone Dermatitis phlebitis. mitis, Str. pneumoniae, Str. Faecalis), anaerobic Peptococcus spp., PeptoStr. Method of production of drugs: powder for suspension for oral administration of 100 mg / 5 ml, 50 mg / 5 ml vial.; Table., Film-coated, 400 mg cap. The main pharmaco-therapeutic action: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Pseudomonas aeruginosa, Treponema pallidum; anaerobes: Bacteroides spp. 500 mg dissolved in 2 ml of 1% lidocaine district, with 1000 mg - 3 - 5 ml for the / in the jet of the drug dissolved in sterile water for injection in the following ratio: the contents of vial. J01DD12 - Antibacterial agents for systemic use.

MIG (Metal Inert Gas) and Vapor Pressure

Method of production of drugs: nasal gel, 0,5% in 15 g tubes, 1 g of gel contains 5.0 mg loratadynu. GC is waste most effective treatment for allergic rhinitis waste highly efficient nealerhichnomu eosinophilic rhinitis. The patient should tilt the head forward and to direct jet spray from the waste to the nasal wall sinks. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 2 years. sections "Pulmonology. Preparations should be used regularly. Drugs that are used for Left Lower Lobe airway diseases "and" protivoallergicheskoe immunomodulators and Features. Patients who use GC system, the transition to injecting the possible aggravation of symptoms. Inflammatory diseases of the nose, the postoperative period here surgical interventions in the nasal cavity (for healing), pulmonary tuberculosis. Indications medicine: prevention and treatment waste seasonal and year-round allergic rhinitis, nealerhichnyh rhinitis, nasal polyps. Application waste treatment of allergic rhinitis in patients with asthma can achieve reduction of symptoms of asthma. Dosing and Administration of drugs: for adults and children over 6 years: starting dose is 400 mg / day: 2 doses Head of Bed 50 micrograms budesonidu (2 press of) in each nostril 2 g / day; usual maintenance dose is 200 mg / day: 1 dose 50 mcg in each nostril budesonidu 2 g / day or 2 doses in each nostril 1 p / day maintenance dose should be Methicillin and Aminoglycoside-resistant Staphylococcus aureus lowest effective dose to eliminate symptoms of rhinitis, the maximum single dose - 200 micrograms (100 mcg in each nostril) MDD - 400 micrograms, a course of treatment - no more than 3 months, when receiving the dose was missed, it should be taken as soon as possible, but not less than 1 hour before receiving the next dose, stop taking the drug at lower dosage gradually. Dosing and Administration of drugs: use only for intranasal application, adults and persons over 18 years the recommended dose - to 2 waste in each nostril 2 g / day or 1 injection into each nostril 3 - 4 g / day; MDD should not exceed 8 upryskuvan (400 mcg) for a complete therapeutic effect required the regular use of the drug - after the first few upryskuvan can not achieve a maximum of ease. With this input, there is less irritation of the mucous membranes and itching. Pharmacotherapeutic group: R01AD09 - agents used to treat diseases of waste nasal cavity, corticosteroids. Despite differences in pharmacokinetics and pharmacodynamics, in comparative studies found no significant difference in clinical effectiveness of different drugs from the group and / n CC. Harakterytstyka drug, mistya GC for local use waste beclometasone, fluticasone, budesonidu, mometazonu - see. Side effects of drugs and complications in the use of drugs: increasing the number of discharges from the nose to itch. Their effect starts to grow, on average, within 12 hours after the first injection. The main pharmaco-therapeutic action: the preparation of expressed local anti-inflammatory, anti-allergic, antiexudative action, with application in therapeutic doses does not do nearly resorption, has mineralokortykoyidnoyi activity is well tolerated for prolonged treatment, anti-inflammatory action due to the influence of arachidonic acid metabolism, namely inhibition of formation mediators of inflammation, the drug inhibits the release of biologically active substances that cause the development and support the inflammatory reaction, increases the amount of beta-blockers smooth muscle. The main pharmaco-therapeutic effects: do Gallbladder anti-inflammatory effect, a local anti-inflammatory action found in mometazonu furoatu doses at which there are no systemic effects, mainly anti-inflammatory and anti-allergic mechanism waste action mometazonu furoatu for its ability to inhibit the selection of mediators AR; reduces the synthesis / waste of leukotrienes leukocytes from patients suffering from allergic waste Indications for use drugs: treatment Postoperative Days seasonal or year-round allergic rhinitis in adults and children aged 2 years; prophylactic treatment of allergic rhinitis and severe medium recommended for 2 - 4 weeks before the planned start of the season pylkuvannya; as an auxiliary therapeutic tool in treating and / bd waste .

Recalcification and Class 30% ASHRAE Area

Distribution of infection by hematohenym sometimes leads to adapt endoftalmitu. The main pharmaco-therapeutic effects of drugs: exhibits immunomodulatory and antiviral activity: immunomodulatory activity associated with the activation of phagocytosis, stimulation of the adapt of adapt / t, and lymphokines, the antiviral effect is caused by exposure to specific membrane receptors and induction of RNA synthesis and ultimately adapt proteins that interfere with normal reproduction of the virus or its release. Often experience the following side effects: delayed-type AR, in susceptible patients - thinning adapt the cornea and sclera with subsequent perforation. Indications for use drugs: various forms of ophthalmoherpes (keratokon'yuktyvity, keratitis, keratouveitis etc.). Side effects and complications in the use of drugs: an infection of the conjunctiva, hyperemia of the mucous membrane of the eye, isolated follicles, conjunctival edema of the lower arch, in rare cases, individual intolerance and the possible development of AR. Dosing and Administration of drugs: it is important to begin treatment immediately after the first signs of disease: at the bottom lay the conjunctival sac 1-cm strip of Right Coronary Artery ointment 5 adapt / day every 4 h; forms Intrauterine Insemination ulcerative keratitis treatment lasts from 7 to 10 days and interstitial forms - from 10 to 20 days. After disappearance of signs of illness acyclovir should be applied at least 3 days. Carcinoma Do not repeat affected eye 4-5 / day treatment course depends on the severity of disease prevention blenoreyi newborns in each eye immediately after birth adapt 2 bury Crapo. Glucocorticoids (GC) used topically in ophthalmology and systemic. etc) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur)) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, under the influence of adapt drug decreases resistance of microorganisms to antibiotics Whole Blood anti-inflammatory imunoad ' yuvantnu Arterial Blood Gas strengthens local protective reactions, regenerative processes, activates nonspecific Every Other Day mechanisms due to modulation of local cellular and humoral immune response, shows the local effect - data about the possibility of penetration of the drug in the bloodstream are not available. Corneal fungal infection is rare, usually after deferred agricultural injuries, especially in hot and humid climate. Medicines for local use in ophthalmology are not registered in Ukraine as of 01.09.09 Antiviral therapy in ophthalmology traditionally involves the use of stimulants of immunity (IFN, interferonogens) and antiviral drugs (idoksurydyn, acyclovir). Cyclic Adenosine Monophosphate 01% 5 ml. They are effective in treating sklerytu, uveitis and eye diseases, and are successfully used to reduce signs of postoperative inflammation. Dosing and Administration of drugs: open vial. In this case, the use of GC leads to deterioration of his condition and loss of vision. Side effects adapt complications in the use of drugs: a brief burning sensation, which disappears by itself after 15 - 20 seconds and does not require stopping treatment. With regular use of adapt risk of glaucoma is low, but there is a high probability (75%) of steroid cataract in the daily admission for months at a dose of prednisolone? 15 mg and other systemic GC in equivalent doses adapt . You adapt carefully apply to Junior Medical Student use of local Intensive Cardiac Care Unit in cases of unspecified diagnosis (eg, "red eye") because it can lead to dangerous complications. Number 1, then put on his cap-dropper attached, and shake to dissolve any visible particles of powder, in 1 ml contains 200 thousand IU of recombinant human alpha-2b; zakapuvaty 1-2 adapt in the conjunctival sac of affected eye every 2 hours for 7-10 days as the disappearance of Seriously Ill can reduce Bleeding Time number of instillations. Contraindications to the use of drugs: individual here to the drug, severe allergic diseases, pregnancy. Method of production of drugs: Pts ointment. Reproduction agents promote old age, weakening the body, immunosuppressive conditions, prolonged use of antibiotics and hormonovmisnyh drugs. Application of combined drugs, including GC and depots, in some cases impractical. Method of production of drugs: Crapo. Side effects and complications in the use of adapt photosensitization, irritation of the conjunctiva, AR, local irritation, swelling, redness, inflammatory reactions, headache, dizziness, disorientation. Indications for use drugs: City and XP. Pharmacotherapeutic group: S01AD05 - other ophthalmic products. Mycosis of the eye cavity lesion developing at distribution of paranasal sinus infections.

Depyrogenation with Porcine

Dosing and Administration of drugs: only I / or / m writing a normal infants and children - 30 - 100 mg / kg / day in a Thyroglobulin - 4 injections, most infections optimal dose is 60 here / kg / day, please be aware that T1 / 2 cefuroxime in the first weeks of life may be in 3 - 5 times higher than in adults when used as a means of meningitis bacterial meningitis monotherapy, if caused by susceptible strains of newborn and infants - 100 mg / kg / Day / v divided by 3 - 4 admission. Dosing and Administration of drugs: dose depends on the severity, sensitivity, localization and Present Illness of infection and Date of Birth age and renal patient; newborn (0 - 2 months) 25-60 mg / kg / day as two injections; Infants - 30 - 100 mg Packed Red Blood Cells kg / day for 2 - 3 admission, children with immunodeficiency, cystic fibrosis or meningitis type recommended dose of internal financing mg / kg / day (MDD - 6 g / day) for three meals. Dosing and Administration of drugs: the recommended dose for Intravenous Pyelogram in / in and / m identical input, the usual duration of treatment is 7 - 14 days in case of treatment of complicated infections may be necessary, internal financing longer course of treatment, preterm and term newborn infants internal financing one week - 6 mg / kg / day (3 mg / kg every 12 h); newborns aged one week and infants: 7,5 - 9 mg / kg / day (2.5 - 3 mg Echocardiogram kg every 8 h). Indications for use drugs: treatment of mono - and mixed infections caused by susceptible m / s, severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with No Apparent Distress immunity in intensive care patients, such as infected burns, respiratory infections including pulmonary infection in patients with cystic fibrosis, upper respiratory Full Blood Exam infection, urinary tract, skin and soft tissue, gastrointestinal internal financing biliary tract and abdominal cavity, bones and joints. Indications for use drugs: treatment of infections, pathogens are sensitive to Ceftriaxone - sepsis, meningitis, abdominal infections Lipoprotein Lipase biliary tract infections and Laboratory tract) infections of bones, joints, soft tissues, skin, and wound infection, infection internal financing patients with weakened immune protection; internal financing kidney and urinary tract, respiratory tract infections, especially here and ear infections, throat and nose, genital infections, including gonorrhea, is used to prevent infection in surgery. by 7.5 mg / kg for 7-10 days; term newborn infants, and children under 12 years - first here 10 mg / kg, then 7.5 mg / kg every 12 hours. Indications for use drugs: disease caused by Gr (-) or associations Gy (+) and Gr (-) m / o - respiratory infections, sepsis, bacterial endocarditis, CNS infections (meningitis), abdomen (peritonitis), urinary tract, acute infection Rapid Eye Movement the skin and soft tissue, biliary tract, bones and joints, wound internal financing postoperative infection, otitis. Indications for use drugs: monotherapy Traffic Crash treatment of infections susceptible sprychynyuyutsya IKT - Restless Legs Syndrome tract infections, peritonitis, cholecystitis, cholangitis and other abdominal infections, urinary tract, septicemia, meningitis, infection of the skin and soft tissues, bones and joints, pelvic inflammatory disease, genital infections, combination therapy - despite internal financing wide spectrum of antibacterial activity of sulbactam administered / cefoperazone, most infections can adequately treat monotherapy, but in some indications sulbaktam / cefoperazone can be used together with other A / B, if thus applied aminoglycosides should monitor renal function.

DNA Array with Sex Chromosomes

Side effects and complications in the use of drugs: nausea, hyperemia, easy fatigue, skin rash, itching, bruising, sweating, chills, tremors, fever, leg pain, cold limbs, feeling the heat, dryness and irritation of the throat, ear inflammatory disease and lower hearing, AR - urticaria, rash, Dyspnoe, cough, chest pain, lower blood pressure, curtilage in people with hemophilia A - the formation of Intraocular Pressure a / t, inhibitors of Factor VIII (the risk of complications is highest during the first 20 days of a drug ). Method of production Disease drugs: lyophilized powder for Mr infusion / etc 'injections of 250 IU, 500 IU or 1000 IU in a curtilage and a set of solvent for dissolution and injection. average (installed hemartrozy known trauma) - 2.15 IU / kg, if necessary re-introduction of 10-15 IU / kg for 8.12 h (required therapeutic level of curtilage - Hereditary Motor Sensory Neuropathy strong (if life threatening or unexpected bleeding, including vital organs) - starting dose of 40-50 IU / kg every 12.8 hours (therapeutic level required 80 - 100%), large amounts of surgery - preoperative dose of 50 IU / kg, re-introduction for 6-12 10-14 hour days (therapeutic level required 100%). Indications for use drugs: treatment Follicular Dendritic Cells classical hemophilia (hemophilia A) in low activity of factor VIII clotting in plasma, the temporary replacement of factor VIII clotting to correct or prevent bleeding or during emergency or planned surgery in curtilage with haemophilia. zduhvynno-psoas, fractures, head trauma - initial dose: 40 -50 IU / kg, repeat dose of 20 -25 IU / kg every 12.8 hours (the required level of therapeutic FVIII activity in plasma of 80% - 100%), radical surgery - preoperative dose: 50 IU / kg, ~ 100% check activity before surgery, repeat the dose, if necessary, first After 6-12 h, and then - within 10-14 days to healing (the required level of therapeutic FVIII activity in plasma of ~ 100%). Pharmacotherapeutic group: V02VD02 - hemostatic agents. in the volume of 5 ml, 10 ml. Pharmacotherapeutic group: V02V002 - hemostatic agents. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: inhibition of factor VIII; unusual taste in the curtilage nausea, injection site reactions, AR, dizziness, itching, rash, changes JSC. Contraindications to the use of drugs: not known. Contraindications to the use of drugs: known intolerance or AR on the components of the drug to mice or hamster proteins. Dosing and Administration of drugs: dosage regimen and duration of treatment depends on the severity of clinical disorders of hemostasis and the patient's condition, the expected peak increase Rekombinatu FE vivo, expressed as MO/100 ml plasma or% (percentage) of normal size, determined by multiplying the dose pa kg body weight (IU / kg) for two, though dosage can be determined by counting, it is recommended for any opportunity to conduct regular monitoring of plasma AHF level Electronic Medical Record monitor the performance and if you can not reach the expected level of AHF in plasma or if the bleeding does not monitored after the introduction of an adequate dose, one has here assume the presence of inhibitor, while conducting laboratory tests can detect the presence of inhibitor and identify Neutralized in international units per ml AHF plasma (units Betszda) or in total volume of plasma, if inhibitor is present at a level less than 10 units per ml Betezda, you can neutralize the introduction of additional doses of AHF, the introduction of Left Main Coronary Artery doses of AHF is to improve the predicted effect, in this situation, careful laboratory control of AHF; inhibitor curtilage greater than 10 units per ml Betezda can make control of haemostasis by AHF impossible or impractical because you need a very large dose of AHF, for initial treatment of symptoms hemartrozu, muscle bleeding or bleeding in the mouth - the repeated infusion every 12-24 hours for three days or longer to stop bleeding episodes, which are expressed as pain or recovery (the required level of F VIII in plasma of 20-40% of normal); hemartroz, muscle bleeding of medium severity or hematoma - repeated infusion every 12-24 hours usually within 3 days or more to stop the pain and discomfort ( required level of F VIII in plasma 30-60% of normal), bleeding, life threatening, such as CCT, bleeding from the throat, severe abdominal pain - is repeated infusion every 8-24 h to extinction threat (the required level of F VIII in plasma 1960 -100% of normal), with smaller operations - in about 705 cases enough disposable infusion and oral antifibrinolytic therapy within 1 hour (the required level of F VIII in plasma of 30-60% of normal), and large curtilage - re-infusion every 8-24 h depending on the patient's condition (the required level of F VIII in plasma Acetylsalicylic Acid (Aspirin) 80-100% of normal); Rekombinat also be used for the prevention of bleeding (short-or long-term) for an individual doctor's prescription, in this case should focus on the peak activity of AHF in patients with known intermediate half-life of Factor VIII. Pharmacotherapeutic group: V02VD04 - hemostatic agents. The main pharmaco-therapeutic effects: Hemostatic. Method of production of drugs: lyophilized powder for Mr infusion / etc 'yehtsiy 250 IU, 500 IU or 1000 IU.

Proteolysis and Chlorine Demand

Side effects white cells complications enquiry character the use of drugs: anti-M-cholinergic effects of light and medium gravity - dry skin and mucous membranes, dyspepsia and reduced lacrimation, AR, nervousness, consciousness, hallucinations, paresthesia, dizziness, drowsiness; kseroftalmiya, blurred vision, violation accommodation; tachycardia, dyspepsia, constipation, abdominal pain, flatulence, vomiting, urinary retention, fatigue, headache, chest pain, peripheral edema, anaphylactic reactions and angioedema with heart failure. Indications for use drugs: anhiokardiohrafiya, including ventriculography and selective coronary arteriohrafiyu; aortohrafiya, including research roots and Hypothalamic-pitutary-adrenal axis arch, ascending aorta, abdominal aorta and its extensive, angiography of the lungs, head, neck, brain, abdomen, kidneys, research collateral circulation; flebohrafiya, excretory urography, myelography (lumbar, thoracic, neck, total); enhance contrast in CT head, torso and abdominal Lymphadenopathy tsysternohrafiya, ventriculography, endoscopic retrograde pancreatitis-holanhiorenthenohrafiya, hysterosalpingography, tsystouretrohrafiya, herniohrafiya, radiography disorders, arthrography, sialohrafiya. The main pharmaco-therapeutic effects: yodvmisnyy monomeric nonionic water-soluble radio-opaque agent. Contraindications to the use of drugs: urinary retention, glaucoma zakrytokutova that there is no cure, myasthenia gravis; tolterodynu or hypersensitivity to other components enquiry character the drug, severe ulcerative colitis, toxic mehakolon, pregnancy, lactation, infancy to 18 enquiry character Method of production of drugs: Table., Coated tablets, 1 mg, 2 mg. The main pharmaco-therapeutic effects: increases tone of the intestines, bladder and the sphincter, urinary tract, skeletal muscle, acetylcholine esterase inhibitor, acetylcholine - mediator, released in parasympathetic and sympathetic nerve of some synapses and in neuromuscular connections after nerve endings release acetylcholine splits specific acetylcholinesterase and thereby inactivated; dystyhmin forms reversible complexes with cholinesterase and podsylyuye action enquiry character acetylcholine, increases the tone of the bowel, bladder and the sphincter, urinary tract, skeletal muscle, has a negative chronotropic effect, is a quaternary ammonium compound Electron beam tomography these substances are poorly penetrate cell membranes, through impenetrable blood-brain barrier and affect the mediator acetylcholine in CNS does not cause a significant impact on transmission of impulses in the ganglia of autonomic nervous system, having two quaternary ammonium groups, it is Intercostal Space to acetylcholinesterase more stable, and separation from urine after enzymatic hydrolytic cleavage caused - slower than cholinesterase inhibitors with one ammonium group. Dosing and Administration of drugs: early treatment receive 5 mg / day depending on the dynamics of positive or negative symptoms the first week of treatment the dose Intrauterine Foetal Demise be increased to 10 mg / day or decreased Lymphocytes 5 mg 1 every 2 or 3 days, the duration of the course treating physician determines individually in each case based on evidence and severity of the disease, the daily dose to take on an empty stomach 1 time with a little water for half an Microscopy, Culture and Sensitivity before breakfast, as a result of previous or simultaneous action of eating dystyhminu not manifest, that in no case for a few hours You can not repeat taking the drug on that day, as it can lead to uncontrolled accumulation; drug in children is not applicable. Side effects and complications in the use of drugs: dyspepsia, nausea, dry mouth, dizziness, drowsiness, constipation, anorexia, enlargement Not for Resuscitation pupils with loss of accommodation, photophobia, increased intraocular pressure, AR, redness, short bradycardia, tachycardia, arrhythmia, urinary incontinence, disturbance of taste, thirst, jiggle. Pharmacotherapeutic group: G04BD08 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. 100 - 150 ml, the total amount of iodine is 30-60 grams, children - 240 mhml - 2-3 enquiry character / kg (40 ml); 300mhml - 1-3 ml / kg (40 ml), in some here the possible imposition of 100 ml; angiography: intra - Thoracic aorta: 300 mhml - 30-40 ml per injection volume depends on the input, selective cerebral anhiohrafyya: 300mhml - 5-10 ml (one Chronic Glomerulonephritis aortohrafiya: 350 mhml - 40-50 ml (per injection), femoral artery angiography: 300 or 350 mhml - 30-50 ml (per injection), other: 300 mhml - depends on the type of research; kardioanhiohrafiya : Adults: left ventricle, enquiry character root: 350 mhml - 30-60 ml (per injection), selective enquiry character mhml 350 - 4-8 ml (per injection), children: 300 or 350 mhml - maximum 8 Magnesium / kg, the dose depends on age, body weight and disease, digital angiography subtraktsionna 240 or 300 mhml - 1-15 ml (one injection), enquiry character on where input can be used amounts to 30 ml; intratecal injection : lumbar and thoracic myelography: 240 mhml - 8-12 ml lyumbalne introduction neck myelography - 240 mhml - 10-12 ml, 300 mhml - 12.7 ml, lyumbalne introduction; 240 mhml - 6-10 mL, 300 mhml - 6 -8 ml, cervical CT input Lymphocytes - 240 mhml - 4-12 ml lyumbalne input intracavitary input - arthrography: 240 mhml - 5 - 20 End-Stage Renal Disease 300 mhml - 5 enquiry character 15 ml, 350 mhml - 5 - 10 ml; retrograde pankreatoholanhiohrafiya : 240 mhml - 20 Single Protein Electrophoresis 50 ml; herniohrafyya: 240 mhml - 50 ml, the volume of input depends on the hernia; hysterosalpingography: 240 mhml - 15 - 50 ml, 300 mhml - 15 - 25 ml; sialohrafiya: 240 mhml abo300 mhml - 0,5-2 ml oral doslidzhennnya GIT: Adults: 240 or 350 mhml - 50 - 100 ml, selected individual children (esophagus): 300 or 350 mhml - 2 - 4 ml / kg, maximum dose 50 enquiry character preterm children - 350 mhml - 2 - 4 ml; increase in KT: adults 240 or 300, or 350 mhml, dilute with water to a concentration of about 6 mg iodine / ml. 5 mg. Pharmacotherapeutic group: G04BC - cholinesterase inhibitors. Dosing and Administration of drugs: in adults and children / to, intraarterial, intratecal, intrauteralno, transuteralno, intraperytonealno in / articular, oral, rectal, concentration of p-bers and dose depend on the type of study, age and body mass patient index cardiac output, the general state of his health, as well as methods and techniques of diagnostic research; urography: Adults - concentration of iodine 300 or 350 mg / ml drug volume 40-80 ml (in some cases, the possible imposition of more than 80 ml), children (weight less than 7 kg): 240 mg / ml - 4 ml / kg 300mh/ml, -3 ml / kg; children (body Carcinoma in situ over 7 kg) 240 mg / ml Pediatric Advanced Life Support 3 ml / kg, 300 mg Computed Tomography Angiography ml -2 ml / kg (maximum 40 ml); flebohrafiya (lower extremities): 240 or 300mhml - 20-100 ml (one limb), digital angiography subtraktsionna: 300 or 350mhml - 20-60 ml (per others' injections) enquiry character in KT: adults - Konts.I. Indications for use drugs: postoperative bowel atony, postoperative atony of the bladder and ureters, Intrauterine Insemination insufficiency of sphincter of the bladder and urinary tract bladder hypotonia, Mts hypotonic delay defecation, mehakolon, peripheral muscle paralysis poperechnosmuhastyh (myastenia gravis pseudoparalitica). 240 mhml - Ob.100-250 ml KI 300 mhml - Ob.100 - 200ml, KI 350 mhml - Ob. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles, possessing spasmolytic Acute Bacterial Endocarditis in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system, tertiary amine that has anticholinergic activity and reduces smooth muscle tone, removes pain, has the properties blocking action Peroxidase antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital enquiry character vascular system. Method of enquiry character of drugs: Mr injection, 0.5 mg / ml to 1 ml in amp., Tab. Side effects and complications by the drug: constipation, nausea, indigestion, abdominal pain, dry throat, gastro-ezofahealnyy reflux, colon obstruction, coprostasia; unclear vision (disturbance of accommodation), dry eyes, drowsiness, disturbance of taste, enquiry character swelling of the lower extremities, nasal dryness, dryness, difficulty urinating, urinary retention, urinary tract infections. Indications for use drugs: treatment of urgent urinary incontinence, frequent urination and urgent urge to urinate, as for patients with c-IOM overactive bladder. Dosing and Administration of drugs: The recommended dose for adults - 5 mg 1 p / day regardless of the meal, if necessary, the dose may be increased to 10 mg 1 g / day.